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Pulmonary Artery Growth After
Palliation of Congenital Heart Disease
With Duct-Dependent Pulmonary Circulation
Arterial Duct Stenting Versus Surgical Shunt
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Maria Teresa Palladino, MD,* Chiara Marrone, MD,‡ Gabriella Farina, MD,†
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Objectives The aim of this study was to compare the pulmonary artery (PA) growth after arterial duct (AD) stenting versus
modified Blalock-Taussig shunt (MBTS) in neonates with congenital heart disease with duct-dependent pulmo-
nary circulation (CHD-DPC).
Background Arterial duct stenting is increasingly deemed a reliable alternative to surgical shunt in CHD-DPC. A stented
duct might better adapt to the PA anatomy than a surgical conduit, thereby promoting a more uniform PA
development.
Methods This study enrolled 27 patients with CHD-DPC submitted to AD stenting (n  13, Group I) or MBTS (n  14,
Group II) at our institution. The PA growth was angiographically assessed with the Nakata and McGoon indexes
as well as the individual PA z-scores. The right-to-left PA diameter ratio was considered as index of uniform
growth.
Results After 10  5 months, both options had promoted a significant increase of the Nakata index (from 136  72
mm/m2 to 294  99 mm/m2, p  0.0001, Group I; from 151  74 mm/m2 to 295  177 mm/m2, p 
0.003, Group II) and McGoon ratio (from 1.5  0.3 to 2.1  0.3, p  0.0001, Group I; from 1.6  0.3 to 2.0 
0.5, p  0.01, Group II). However, the surgical shunt had caused a worsening of the left-to-right PA diameter
ratio compared with AD stenting (0.9  0.1 Group I vs. 1.6  0.9 Group II, p  0.01), due to preferential growth
of the PA contralateral to the shunt.
Conclusions Percutaneous AD stenting is as effective as MBTS in promoting a global PA growth in CHD-DPC. In addition, it
ensures an even distribution of the pulmonary blood flow, thereby promoting a more balanced pulmonary vas-
cular development than MBTS. (J Am Coll Cardiol 2009;54:2180–6) © 2009 by the American College of
Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.07.043e
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Prterial duct (AD) stenting is increasingly deemed an
ffective alternative to surgical systemic-to-pulmonary shunt
n congenital heart disease with duct-dependent pulmonary
irculation (CHD-DPC) (1–7). This option has been ad-
ocated either in high-risk patients unsuitable for primary
epair or whenever a short-term pulmonary blood flow
upport is anticipated. Allowing the stent to conform to the
ulmonary artery (PA) anatomy might have favorable effects
n the development of the pulmonary vascular tree, due to
rom *Cardiology and †Pediatric Cardiac Surgery, A.O. Monaldi, Second University
f Naples, Naples, Italy; and ‡Clinical Medicine, Cardiovascular and Immunologic
ciences, Federico II University of Naples, Naples, Italy.a
Manuscript received May 7, 2009; revised manuscript received July 13, 2009,
ccepted July 20, 2009.ven distribution of the pulmonary blood flow. However, no
tudy so far has specifically addressed this hypothesis or
ompared the effects of ductal flow versus conventional
odified Blalock-Taussig shunt (MBTS) in neonates with
HD-DPC.
The aims of this study was to evaluate the ability of AD
tenting to promote the growth of the PAs in newborns
ith duct-dependent pulmonary circulation and to compare
he mid-term results of this approach with respect to MBTS
n a single tertiary referral center.
ethods
atient population. Between April 2003 and January 2009,
total of 132 neonates and infants underwent either AD
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December 1, 2009:2180–6 Pulmonary Growth in Duct-Dependent Circulationtenting or MBTS at our institution, as palliation of CHD-
PC. The AD stenting was attempted in patients at high
urgical risk or whenever a short-term support to the pulmo-
ary circulation was anticipated. Stenting procedure was effec-
ively completed in 45 of 49 patients (91.8%). Procedural
orbidity and mortality were 6.1% and 0%, respectively.
verall, in-hospital mortality was 6.1% (n 3), not related to
he interventional procedure. The AD stenting patients had an
ge range of 1 to 84 days (mean 22  39 days) and a weight
ange of 1.2 to 5.5 kg (mean 3.2 0.9 kg). Surgical shunt was
erformed in cases of extreme AD tortuosity or when a
onger-term support to the pulmonary circulation was antici-
ated because of planned surgical repair with prosthetic con-
uits. Eighty-seven patients underwent MBTS. Their age
ange was 7 to 76 days (mean 21 30 days), and their weight
ange was 2.7 to 4.8 kg (mean 3.3  1.2 kg). Surgical
orbidity and mortality were 6.9% and 3.5%, respectively.
The criterion for inclusion in this study was the availabil-
ty of the pulmonary angiography before either palliative
rocedures and over a mid-term follow-up.
Twenty-seven of the 45 patients submitted to AD stent-
ng spontaneously improved over the follow-up and did not
eed any further therapeutic procedures. The remaining 18
nderwent follow-up cardiac catheterization before surgical
epair, due to progressive decrease of the systemic oxygen
aturation. Five patients were excluded from the study,
ecause the stented AD supplied an isolated PA (n  3) or
ilateral ADs supplied discontinuous PAs (n 2). Thus, 13
atients were enrolled in the study as Group I. Five of them
ad complete duct-dependency of the pulmonary circula-
ion due to trivial or absent antegrade pulmonary blood
ow, whereas 8 patients showed a mild-to-moderate ante-
rade pulmonary flow in addition to the ductal flow.
Of 87 patients who received MBTS, only 14 underwent
re-procedural angiography due to suspected complex ana-
omy (n 10) or a failed attempt of ductal stenting (n 4),
nd these form Group II. Eight of these had the MBTS as
he sole pulmonary blood flow source, and 6 showed
dditional pulmonary flow sources.
Demographic and clinical data of the patients enrolled in
his study are summarized in Table 1. No difference was
ound in terms of additional pulmonary flow apart from
ither stented AD or surgical shunt between the groups.
nterventional procedure. The AD stenting was performed
nder general anesthesia following a previously described
rotocol (7). Prostaglandin infusion was stopped 6 h before the
rocedure to achieve a stable ductal constriction to grip the
tent after its deployment. Arterial vascular access was used to
mage the AD and to perform the stenting procedure. The AD
orphology, size, and length were assessed in multiple angio-
raphic views, and the measurements were made with the
atheter as reference. After AD visualization, a 0.014-inch
oronary guidewire (Crosswire NT, Terumo Corporation,
okyo, Japan; Balance Middleweight, Guidant Corporation,
anta Clara, California) was passed through the duct and
nchored in a distal lower lobe PA branch. Positioning and
aeployment of the stent were an-
iographically guided by repeat in-
ections through the introducer
heath or coronary guiding cathe-
ers. Open-cell, high-flexibility
obalt-chromium stents (Vision,
uidant Corporation; Driver,
edtronic, Inc., Minneapolis, Min-
esota) were used. The length of the
tent was chosen to cover the entire
ength of the AD, whereas the di-
meter of the stent was chosen indi-
idually, on the basis of the size of
he patient and the expected time for
hich palliation was needed. The
tent diameter was always approxi-
ately 75% of the proposed surgical
hunt size in the belief that it acted more as a central shunt than
Blalock-Taussig shunt. After stent deployment, repeat angiog-
aphies were performed in multiple views to exclude any incom-
lete covering of the duct as well as to evaluate any potential
tent-related PA stenosis.
Surgical shunt was made through left or right thoracotomy
n the fourth intercostal space with poly-tetrafluoroethylene
rafts (GORE-Tex, W.L. Gore and Associates, Ltd., Living-
ton, Scotland) interposed from the undivided innominate or
ubclavian arteries to the mid-segment of the PA contralat-
ral to the aortic arch. The size of the graft was chosen by
he operating surgeon on the basis of the size of the
ulmonary and subclavian arteries. All anastomoses were
erformed with 6.0 or 7.0 synthetic suture material (Pro-
ene, Ethicon, Somerville, New Jersey).
emographic Data at Control Cardiacatheterization of Infants Submitted torcu aneous or Surgical Pa liation of CHDi Duct-Depende Pu monary Blood Flow
Table 1
Demographic Data at Control Cardiac
Catheterization of Infants Submitted to
Percutaneous or Surgical Palliation of CHD
With Duct-Dependent Pulmonary Blood Flow
Arterial Duct Stenting (n  13, Group I)
Age (months) 8.1 3.6 (range 3–15, median 7)
Weight (kg) 5.7 1.8 (range 3.6–10.6, median 5)
Cardiac malformation
Tetralogy of Fallot 2
Pulmonary atresia with intact
ventricular septum*
6
Complex CHD with pulmonary atresia/
stenosis
5
Modified Blalock-Taussig Shunt (n 14, Group II)
Age (months) 13 7 (range 6–22, median 9)
Weight (kg) 8.7 1.5 (range 7.3–11.5, median 8)
Cardiac malformations
Tetralogy of Fallot 6
Pulmonary atresia with intact
ventricular septum†
2
Complex CHD with pulmonary atresia/
stenosis
6
In 5 cases after pulmonary valve perforation and angioplasty; †after pulmonary valve perforation
Abbreviations
and Acronyms
AD  arterial duct
Ao  aorta
CHD-DPC  congenital
heart disease with duct-
dependent pulmonary
circulation
LPA  left pulmonary
artery
MBTS  modified Blalock-
Taussig shunt
PA  pulmonary artery
RPA  right pulmonary
arterynd angioplasty.
CHD  congenital heart disease.
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Pulmonary Growth in Duct-Dependent Circulation December 1, 2009:2180–6After either palliation, aspirin treatment was started at 3
o 5 mg/kg/day and continued until surgical repair.
ngiographic measurements. Pulmonary angiography
as performed in posteroanterior, right anterior oblique,
nd 4-chamber views. The left (or contralateral to the
hunt) and right (or ipsilateral to the shunt) PAs were
easured just before their first branching point. The diam-
ter of the descending aorta was measured at the diaphragm
evel. All values were obtained during ventricular systole
nd, if possible, from the same angiographic frame with the
atheter size as reference. The indexed sum of the cross-
ectional PA areas (Nakata index) (8) and the ratio of the
um of the diameters of both PAs to the diameter of the
escending aorta (McGoon ratio) (9) were considered as
eing indicative of global growth of the pulmonary vascular
ree. The diameter ratio of any main PA to the descending
orta as well as the right and left PA z-scores obtained from
eb nomograms were considered indexes of individual
rowth. Finally, the left-to-right PA diameter ratio was
onsidered to indicate balanced vascular growth.
tatistical analysis. All analyses were performed with
PSS for Windows version 13.0 (SPSS, Inc., Chicago,
llinois). Results are expressed as mean SD. Comparisons
ithin either group and between groups were performed
ith the paired and unpaired Student t test, respectively.
ignificance was defined as p  0.05.
esults
he AD stenting was achieved with stents dilated to 3.3 
.4 mm (range 2.5 to 4 mm). In all but 1 patient the surgical
hunt was performed on the right side, with a prosthetic
onduit of 4.4  0.3 mm (p  0.001 vs. AD stenting).
ost-procedure oxygen saturation did not differ between the
roups (87  5% vs. 86  3%, p  NS), as it was at
ollow-up cardiac catheterization (81  7% vs. 82  3%,
 NS). The latter was performed after 10  5 months
range 3 to 22 months, median 8 months) and was signif-
cantly earlier in Group I (7 3 months vs. 12 6 months,
 0.01), because in the majority of Group II patients the
urgical repair was slightly postponed due to the expected
se of a prosthetic conduit. At the time of control angiog-
aphy, both approaches had promoted a significant growth
f the pulmonary vascular tree (Figs. 1 and 2) in terms of
akata index (from 136  72 mm2/m2 to 294  99
m2/m2 in Group I, p  0.0001; from 151  74 mm2/m2
o 295  177 mm2/m2 in Group II, p  0.003) (Fig. 3A)
nd McGoon ratio (from 1.5  0.3 to 2.1  0.3 in Group
, p  0.0001; from 1.6  0.3 to 2.0  0.5 in Group II,
 0.01) (Fig. 3B), without any difference between the
roups (Table 2). However, the AD stenting had promoted
more uniform development of the main PAs with respect
o the MBTS (Table 2), as confirmed by a significant
orsening of the left-to-right diameter ratio in Group II
from 1.1  0.6 to 1.6  0.9, p  0.02) due to preferential
rowth of the PA opposite to the shunt (131  75% vs. b0  54% of the ipsilateral PA, p  0.01) (Fig. 4). These
hanges resulted in a significant difference in the left-to-
ight PA diameter ratio between the groups at follow-up
ngiographic control (0.9  0.1 in Group I vs. 1.6  0.9 in
roup II, p  0.01) (Fig. 5).
iscussion
espite current trends toward early primary repair, surgical
ystemic-to-pulmonary shunt is still an invaluable palliative
ption in some high-risk neonates with duct-dependent
ulmonary circulation who are likely to achieve a biventricu-
ar repair and in all patients with single-ventricle physiology
estined to the Fontan track. However, the effect of the
hunt on the PAs remains controversial, especially with
egard to distortion and stenosis (10–23). These known
otential shunt-related complications have been reported in
s high as 36% of neonates and small children (14) and
ight increase morbidity and mortality in subsequent cor-
ective surgery (15–18). However, even perfect shunts might
esult in unbalanced development of the central pulmonary
essels, with preferential growth of the ipsilateral (19–21) or
ontralateral PA (16,22). Among the several factors that
ight influence vascular growth, conduit geometry and
irection of flow from the shunt to the main PAs might play
major role (24). More centrally placed shunts result in
etter distribution of blood flow to the lungs, thereby
nhancing symmetrical pulmonary vascular growth and
inimizing any iatrogenic deformation of the pulmonary
Figure 1 Mid-Term Consequences of a
Modified Blalock-Taussig Shunt
Discrepant left-to-right pulmonary artery growth in a patient with tricuspid and
pulmonary atresia submitted to right modified Blalock-Taussig shunt (), as
imaged 8 months after the surgical palliation. LPA  left pulmonary artery;
RPA  right pulmonary artery.ranches. To achieve this goal, several technical modifica-
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December 1, 2009:2180–6 Pulmonary Growth in Duct-Dependent Circulationions of surgical palliation (20,25–27) or various percutane-
us approaches have been proposed (1–7,28). Over the last
ew years, AD stenting has gained wide acceptance as a
eliable alternative to systemic-to-pulmonary shunt in pa-
ients with CHD-DPC. This option is currently deemed
afer and more effective than palliative surgery in high-risk
atients (29–32), because it is possible to tailor the shunt
agnitude to the patient’s size and pulmonary anatomy. In
ddition, the shorter durability of the stented duct (2) might
e used as a temporary bridge toward spontaneous improve-
ent in patients in whom a short-term pulmonary blood
ow support is anticipated, compared with a conventional
urgical shunt. However, the capability of the stented duct
o promote a significant and balanced PA growth in
Figure 2 Pulmonary Artery Growth After Arterial Duct Stenting
Pulmonary artery angiography before (A) and after (B) the arterial duct stenting
in a patient with tetralogy of Fallot. Ao  aorta; other abbreviations as in Figure 1.HD-DPC has so far never been specifically addressed.onforming the stent to the size and angulations of the
ain PAs might theoretically result in an even distribution
f pulmonary blood flow and thereby promote uniform
ascular development. This hypothesis is supported so far
nly by scanty data from large series reporting the global
rowth of the pulmonary vascular tree (6,7). However, no
ata exist on the growth of the individual PAs and the
eft-to-right balance resulting from stabilized ductal flow. In
ddition, no comparison between this approach and con-
entional surgical shunt has been reported in published data
o far.
In our study, the stented duct resulted in similar systemic
xygen saturation over a mid-term follow-up, even though
t was dilated to a smaller diameter than conventional
BTS. In addition, it promoted a global growth of the
ulmonary vascular bed similar to the surgical shunt, even if
t was left in place for a significantly shorter time. Further-
ore, this approach promoted a more uniform development
f the main PAs than surgical palliation, as confirmed by a
ignificantly better left-to-right PA diameter ratio at control
ngiography. This was possibly due to an optimal angle
etween the AD, maintained with highly flexible coronary
tents, and the main pulmonary branches that allowed
ignificant and balanced pulmonary blood flow. Conversely,
Figure 3 Global Growth of the Pulmonary
Artery Tree After AD Stenting or MBTS
Nakata Index (A) and the McGoon Ratio (B) changes after percutaneous or
surgical palliation. AD  arterial duct; MBTS  modified Blalock-Taussig shunt.
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Pulmonary Growth in Duct-Dependent Circulation December 1, 2009:2180–6he surgical shunt produced both the overgrowth of the
ontralateral PA and a lesser development of the ipsilateral
A compared with the percutaneous approach, presumably
ue to unfavorable graft geometry and flow direction to the
ulmonary vascular bed. Our findings confirm the data
lready reported in a different physiopathologic model (i.e.,
ypoplastic left heart syndrome) (33,34), after classic Nor-
ood stage I or its Sano modification. In these studies, a
ignificant left-to-right PA size discrepancy was found after
lassic Norwood palliation, despite a similar growth of the
ulmonary vascular tree promoted by either MBTS or right
entricle-main PA conduit, presumably due to uneven
istribution of the pulmonary blood flow.
tudy limitations. The study aims to compare the mid-
erm effect of AD stenting with conventional MBTS,
ecause palliation of CHD-DPC might be hampered by
ngiographic Changes After Arterial Duct StentingGroup I) or Modified Blalock-Taussig Shunt (Group II)Table 2 Ang ographic Change After Ar rial Duct Stenting(Group I) or Modified Blalock-Taussig Shunt (Group II)
Variable
Group I
(n  13)
Group II
(n  14)
p Value
(Between Groups)
Left PA z-score
Pre- 0.6 1.7 0.5 2.1
Post- 1.3 1.2 2.1 2.2
% increase 93 43 131 75 NS
p value (within groups) 0.0001 0.0001
RPA z-score
Pre- 0.6 1.4 1.0 1.6
Post- 1.2 1.2 0.2 3.3
% increase 95 33 70 54 NS
p value (within groups) 0.0001 0.0001
LPA/Ao diameter ratio
Pre- 0.8 0.2 0.8 0.4
Post- 1.0 0.2 1.2 0.5
% increase 35 26 79 73 NS
p value (within groups) 0.0001 0.05
RPA/Ao diameter ratio
Pre- 0.8 0.2 0.7 0.2
Post- 1.1 0.1 0.9 0.3
% increase 35 19 22 48 NS
p value (within groups) 0.0001 0.01
LPA/RPA diameter ratio
Pre- 1.0 0.1 1.1 0.6
Post- 0.9 0.1 1.6 0.9
% increase 2 11 44 55 0.01
p value (within groups) NS 0.02
Nakata index (mm2/m2)
Pre- 136 72 151 74
Post- 294 99 295 177
% increase 156 124 108 104 NS
p value (within groups) 0.0001 0.005
McGoon ratio
Pre- 1.5 0.3 1.6 0.3
Post- 2.1 0.3 2.0 0.5
% increase 41 27 33 36 NS
p value (within groups) 0.0001 0.01
o  aorta; LPA  left pulmonary artery; PA  pulmonary artery; RPA  right pulmonary artery.ome possible limitations. First, the patient population isuite small, thereby precluding any reliable multifactorial
nalysis of the impact of the patient’s demographic profile
n the procedure or the accessory pulmonary blood flow on
Figure 4 Development of the Individual
PAs After AD Stenting or MBTS
Mid-term changes of the pulmonary artery (PA) z-scores after percutaneous (A)
or surgical (B) palliation. RPA  right pulmonary artery; other abbreviations as
in Figure 3.
Figure 5 Changes of the Left-to-Right Diameter Ratio
of the Main PAs After AD Stenting or MBTSAbbreviations as in Figures 3 and 4.
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December 1, 2009:2180–6 Pulmonary Growth in Duct-Dependent Circulationulmonary vascular development. However, in this era of
arly surgical repair, either approach should be viewed as a
hort-term palliation, thus making less influent these vari-
bles on PA growth promotion. Second, the retrospective
nd nonrandomized nature of the enrollment might have
ntroduced a potentially significant selection bias to evaluate
he impact of either palliative options. However, there was
o significant difference between the groups in terms of
emographic data or pre-procedural PA size, and both
ptions produced similar levels of percutaneous oxygen
aturation over the study period. Third, the surgical shunt
as left in-situ significantly longer than the stented duct,
nd this might have amplified any left-to-right growth
mbalance. However, the growth of the pulmonary arterial
ree poorly correlates with duration of follow-up, as previ-
usly reported (14). In addition, these results did not differ
ven when we compared the small subset of the surgical
roup (n  9) matched against the percutaneous group in
erms of duration of palliation. Finally, stent re-dilation
ight be successfully performed whenever the clinical con-
itions warrant, to prolong the lifespan of this therapeutic
ption, as consistently reported in published data (4,6,7).
onclusions
ercutaneous AD stenting with high-flexibility coronary stents
s as effective as MBTS in promoting a significant PA growth
n CHD-DPC over a mid-term follow-up. In addition, this
pproach produces a more balanced growth of the PAs with
espect to conventional systemic-to-pulmonary shunt, pre-
umably due to a more uniform pulmonary blood flow.
hus, AD stabilization could be proposed as the first-choice
pproach in the short-term palliation of these malforma-
ions, in view of spontaneous improvement or early and
afer corrective surgery. This option might be advisable even
f a longer-term palliation was needed, because the stent
e-dilation could be successfully performed to prolong the
ifespan of the stented duct.
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